Morgan Stanley Eliem Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 78,181 shares of ELYM stock, worth $321,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,181

Previous 9,883 691.07%

Holding current value

$321,323

Previous $70,000 467.14%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.98 - $8.93 $340,124 - $609,901	68,298 Added 691.07%	78,181 $397,000
Q2 2024 Oct 17, 2024	BUY	$2.6 - $10.2 $21,252 - $83,374	8,174 Added 478.29%	9,883 $70,000
Q2 2024 Aug 14, 2024	BUY	$2.6 - $10.2 $21,252 - $83,374	8,174 Added 478.29%	9,883 $70,000
Q1 2024 Oct 17, 2024	SELL	$2.54 - $2.98 $20,761 - $24,358	-8,174 Reduced 82.71%	1,709 $4,000
Q4 2023 Aug 16, 2024	SELL	$2.45 - $2.85 $20,026 - $23,295	-8,174 Reduced 82.71%	1,709 $4,000
Q2 2023 Aug 14, 2023	SELL	$2.34 - $3.72 $141,820 - $225,458	-60,607 Reduced 97.26%	1,709 $4,000
Q1 2023 May 15, 2023	BUY	$2.3 - $4.64 $142,993 - $288,473	62,171 Added 42876.55%	62,316 $180,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.69 $11,462 - $17,055	-4,622 Reduced 96.96%	145 $0
Q3 2022 Nov 14, 2022	SELL	$2.72 - $3.97 $5,061 - $7,388	-1,861 Reduced 28.08%	4,767 $15,000
Q2 2022 Oct 27, 2022	BUY	$2.77 - $8.4 $2,620 - $7,946	946 Added 16.65%	6,628 $20,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $8.4 $2,620 - $7,946	946 Added 16.65%	6,628 $20,000
Q1 2022 Oct 27, 2022	SELL	$8.01 - $13.15 $7,577 - $12,439	-946 Reduced 14.27%	5,682 $47,000
Q1 2022 May 13, 2022	SELL	$8.01 - $13.15 $35,564 - $58,386	-4,440 Reduced 43.86%	5,682 $47,000
Q4 2021 Feb 14, 2022	BUY	$8.61 - $20.47 $34,517 - $82,064	4,009 Added 65.58%	10,122 $106,000
Q3 2021 Nov 15, 2021	BUY	$14.45 - $28.61 $88,332 - $174,892	6,113 New	6,113 $110,000

Others Institutions Holding ELYM

# of Institutions

Shares Held

53.1M

Call Options Held

Put Options Held

View Full List

About Eliem Therapeutics, Inc.

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

More about ELYM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account